Baldwin Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3
| Closed | -$3.15K | – | 830 |
|
|
2024
Q3 | $3.15K | Buy |
+3
| New | +$3.15K | ﹤0.01% | 913 |
|
|
2023
Q2 | – | Sell |
-49
| Closed | -$40.3K | – | 791 |
|
|
2023
Q1 | $40.3K | Sell |
49
-110
| -69% | -$90.4K | ﹤0.01% | 440 |
|
|
2022
Q4 | $115K | Sell |
159
-195
| -55% | -$141K | 0.01% | 294 |
|
|
2022
Q3 | $244K | Sell |
354
-26
| -7% | -$17.9K | 0.03% | 154 |
|
|
2022
Q2 | $225K | Sell |
380
-567
| -60% | -$336K | 0.03% | 167 |
|
|
2022
Q1 | $661K | Sell |
947
-12,661
| -93% | -$8.84M | 0.07% | 96 |
|
|
2021
Q4 | $8.59M | Buy |
13,608
+791
| +6% | +$500K | 0.86% | 34 |
|
|
2021
Q3 | $7.76M | Buy |
12,817
+625
| +5% | +$378K | 0.86% | 36 |
|
|
2021
Q2 | $6.81M | Buy |
12,192
+462
| +4% | +$258K | 0.74% | 39 |
|
|
2021
Q1 | $5.55M | Buy |
11,730
+395
| +3% | +$187K | 0.66% | 45 |
|
|
2020
Q4 | $5.48M | Buy |
11,335
+3,251
| +40% | +$1.57M | 0.69% | 43 |
|
|
2020
Q3 | $4.53M | Buy |
8,084
+2,036
| +34% | +$1.14M | 0.62% | 47 |
|
|
2020
Q2 | $3.77M | Buy |
6,048
+448
| +8% | +$279K | 0.55% | 51 |
|
|
2020
Q1 | $2.73M | Buy |
+5,600
| New | +$2.73M | 0.48% | 54 |
|